Califf In Conversation: “Decimated” FDA Teams Endanger Biologics Progress

In Vivo spoke to the previous commissioner of the US FDA about recent ongoings at the agency, and where he believes policy should be directed for patient and industry benefit.

Robert Califf. (Alamy)
Ex-FDA Comissioner Robert Califf • Source: Alamy

More from Leadership

More from Market Access